Virtu KCG Holdings’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Virtu KCG Holdings’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-44,847	Closed	-$120K	–	3901
2016 Q4	$120K	Buy	44,847 +20,142	+82%	+$62.5K	﹤0.01%	2844
2016 Q3	$81K	Buy	+24,705	New	+$80.8K	﹤0.01%	2690
2016 Q1	–	Sell	-16,572	Closed	-$54K	–	3849
2015 Q4	$54K	Buy	+16,572	New	+$55.6K	﹤0.01%	3143
2015 Q2	–	Sell	-30,635	Closed	-$26K	–	3879
2015 Q1	$26K	Buy	30,635 +7,044	+30%	+$3.33K	﹤0.01%	2924
2014 Q4	$9K	Buy	+23,591	New	+$50.3K	﹤0.01%	3660
2014 Q1	–	Sell	-23,325	Closed	-$140K	–	4215
2013 Q4	$140K	Sell	23,325 -34,338	-60%	-$234K	﹤0.01%	3309
2013 Q3	$379K	Buy	+57,663	New	+$377K	﹤0.01%	2341

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BAS

Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

Virtu KCG Holdings's NYMX Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Nymox Pharmaceutical Corp (NYMX) in Q1 2017, closing a stake of 44,847 shares — an estimated $120K sold.

Virtu KCG Holdings first reported a position in NYMX in Q3 2013 and held it in 7 quarters. The position peaked at $379K in Q3 2013. 29 funds tracked by Wall St. Rank hold NYMX as of Q1 2017.

Virtu KCG Holdings reported no remaining Nymox Pharmaceutical Corp position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 44,847 Nymox Pharmaceutical Corp shares in Q1 2017, an estimated $120K.
Virtu KCG Holdings first reported a position in Nymox Pharmaceutical Corp in Q3 2013 and held it in 7 quarters.
Virtu KCG Holdings's Nymox Pharmaceutical Corp position peaked at $379K in Q3 2013.
29 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.